Latest Bioprocessing Technology Institute Stories
A*STAR scientists find new targets for modulating antibody response Singapore, Sept 1, 2014 - (ACN Newswire) - Scientists from A*STAR's
Glycomics an emerging field with implications for understanding and treating human diseasesSingapore,
Singapore, Mar 19, 2013 - (ACN Newswire) - VeriStem Technologies, a spin-off from A*STAR's Bioprocessing Technology Institute (BTI), has been awarded the Biospectrum Asia-Pacific Emerging Companies of
This discovery may potentially cure patients of multiple myelomaSingapore, Dec 13, 2012 - (ACN Newswire) - Singapore scientists have identified FAIM, a molecule that typically
Researchers from A*STAR Singapore took lead roles in a study that identified a portion of the genome mutated during long-term culture of human embryonic stem cells (hESCs).
- Growing in low tufty patches.